Topic: How To Invest

Q: I would like your opinion on Veeva Systems. Thanks and regards.

Article Excerpt

A: Veeva Systems, $254.12, symbol VEEV on New York (Shares outstanding: 135.0 million; Market cap: $38.6 billion; www.veeva.com), provides Internet-based customer relationship management (CRM) software to the life sciences, cosmetics and consumer-products industries. The San Francisco-based company has more than 850 customers, ranging from large pharmaceutical firms to biotech startups. In September 2018, Veeva launched Veeva Vault Clinical Data Management System (CDMS)—a cloud application to help life sciences companies manage their clinical data. Cloud apps let users access software through the web and store data files on remote servers. Veeva Vault combines multiple tools in one app so that drug developers can make faster and better decisions. Over the last five years, the company’s revenue has risen 169.8%, from $409.2 million in 2015 to $1.10 billion in 2019. Earnings rose 366.3%, from $74.5 million in 2015 ($0.52 a share) to $347.4 million ($2.19) in 2019. In the three months ended April 30, 2020, the company’s overall revenue rose 37.7%, to $337.1 million from $244.8…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.